Renal LRP2 expression in man and chicken is estrogen-responsive  by Plieschnig, Julia A. et al.
Gene 508 (2012) 49–59
Contents lists available at SciVerse ScienceDirect
Gene
j ourna l homepage: www.e lsev ie r .com/ locate /geneRenal LRP2 expression in man and chicken is estrogen-responsive
Julia A. Plieschnig a, Eva T. Gensberger a, Tarek M. Bajari b, Wolfgang J. Schneider a, Marcela Hermann a,⁎
a Max F. Perutz Laboratories, Department of Medical Biochemistry, Medical University of Vienna, Dr. Bohr-Gasse 9/2, A-1030 Vienna, Austria
b Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Währinger Gürtel 18–20, A1090 Vienna, AustriaAbbreviations: Apo, Apolipoprotein; BRCA1, Breast ca
DAPI, 4′,6′-diamidino-2′-phenylindole; ERE, Estrogen res
receptor; GAPDH, Glycerinaldehyd-3-phosphat-Dehydrog
protein; gg, Gallus gallus; Gp330, Glycoprotein 330; GSK
GST, Glutathione S-tranferase; HDL, High-density lipopro
onic kidney cells;HRP, Horseradish peroxidase; hs, Homo s
LA-repeat, LDL receptor type A-repeat; LDL, Low-density l
lipoprotein receptor; LRP, Low-densitiy lipoprotein rec
nickel-nitrilotriacetic acid; ORF, Open reading frame; PKA
kinase C; RAP, Receptor-associated protein; SDS, Sodium
mone binding globulin; Sp, Stimulating protein; SRE, Ste
Very low-density lipoprotein; VLDLR, Very low-density lip
⁎ Corresponding author at: Department of Medical Bio
A-1030 Vienna, Austria. Tel.: +43 1 4277 61820; fax: +
E-mail address: marcela.hermann@meduniwien.ac.a
0378-1119 © 2012 Elsevier B.V.
http://dx.doi.org/10.1016/j.gene.2012.07.041
Open access under CC BYa b s t r a c ta r t i c l e i n f oArticle history:
Accepted 15 July 2012
Available online 31 July 2012
Keywords:
LRP2
LDL-R gene family
Sex speciﬁcity
Estrogen‐responsiveness
ChickenIn mammals, low-density lipoprotein receptor-related protein-2 (LRP2) is an endocytic receptor that binds
multiple ligands and is essential for awide range of physiological processes. To gain new insights into the biology
of this complex protein,we have initiated themolecular characterization of the LRP2 homolog from an oviparous
species, the chicken (Gallus gallus). The galline LRP2 cDNA encodes a membrane protein of 4658 residues.
Overall, the galline and human proteins are 73% identical, indicating that the avian gene has been well conserved
over 300 million years. Unexpectedly, LRP2 transcript and protein levels in the kidney of females and estrogen-
treated roosters were signiﬁcantly higher than those in untreated males. The estrogen-responsiveness of avian
LRP2 may be related to the dramatic differences in lipoprotein metabolism between mature roosters and laying
hens. Newly identiﬁed potential estrogen-responsive elements (ERE) in the human and galline LRP2 gene,
and additional Sp1 sites present in the promoter of the chicken gene, are compatible with both direct estrogen
induction via the classical ligand-induced ERE pathway and the indirect transcription factor crosstalk pathway
engaging the Sp1 sites. In agreement with this assumption, estrogen induction of LRP2 was observed not only
in primary cultured chicken kidney cells, but also human kidney cell lines. These ﬁndings point to novel regula-
tory features of the LRP2 gene resulting in sex-speciﬁc receptor expression.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license. 1. Introduction
LRP2, also called megalin or glycoprotein-330 (gp330), was orig-
inally identiﬁed as the pathogenic autoantigen of Heymann nephritis
in rats (Kerjaschki and Farquhar, 1982, 1983). In mammals, this
multifunctional cell-surface receptor, the largest member of the low-
density lipoprotein receptor (LDL-R) family, is a 600 kDa protein
(Nykjaer and Willnow, 2002). LRP2 is a classical endocytic receptor,
which is expressed on the apical surface of absorptive epithelia in a
number of different tissues, and mainly in glomeruli and cells of the
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-NC-ND license. structurally and functionally different ligands (Birn, 2006; Gliemann,
1998; Herz and Strickland, 2001), including vitamins, carrier proteins,
lipoproteins, enzymes, hormones, and others (reviewed in (Birn, 2006;
Willnow and Nykjaer, 2010)). Importantly, the binding of most ligands
is strictly Ca2+-dependent (Christensen et al., 1992; Hjalm et al., 1996),
which is a characteristic property of the LDL receptor family. Various stud-
ies have described LRP2 as a carrier for lipoprotein cholesterol and vita-
mins A and D (Liu et al., 1998; Moestrup and Verroust, 2001). The
receptor binds complexes of 25-OH vitamin D3 with vitamin D binding
protein (DBP) (Marino et al., 2001; Nykjaer et al., 2001) and of vitamin
Awith retinol binding protein (RBP) (Christensen et al., 1999). Following
internalization, the carrier proteins are degraded in lysosomes, while the
vitamins are released into the cytosol to perform their respective func-
tions. This mechanism prevents urinary loss of vitamins in the proximal
tubules. Loss of LRP2 expression, e.g. in knockout mice, results in vita-
min D deﬁciency and in bone-calciﬁcation defects, underscoring the
receptor's prominent role in vitamin homeostasis (Muller et al.,
2003; Nykjaer et al., 2001). Accordingly, decreased renal LRP2 ex-
pression has been demonstrated in certain diseases characterized
by proteinuria (Christensen et al., 2003; Norden et al., 2002; Piwon
et al., 2000).
In mammals, LRP2 has been identiﬁed as a receptor mediating the
uptake of sex hormone binding globulin (SHBG), a carrier protein for
androgens and estrogens (Hammes et al., 2005). Steroid hormones
act by entering target cells and subsequently associating with nuclear
hormone receptors that activate transcription of steroid-responsive
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as the male and female reproductive organs (Hammes et al., 2005;
Zheng et al., 1994), in agreement with its prominent role in steroid
hormone function.
LRP2 also plays an important role in the formation of the central
nervous system. Homozygous disruption of the corresponding gene
leads to malformation of the forebrain and cephalic midline structure,
known as holoprosencephaly (Nykjaer and Willnow, 2002; Willnow et
al., 1996). Based on its ability to bind apolipoprotein B-100 (Stefansson
et al., 1995), apolipoprotein E, and lipoprotein lipase (reviewed in
(Christensen and Birn, 2002)), LRP2 has discrete roles in lipoprotein
metabolism. Furthermore, LRP2 binds apolipoprotein J (clusterin)
with high afﬁnity (Kounnas et al., 1995) and can mediate HDL endocy-
tosis via forming a complex with cubilin and amnionless (Pedersen et
al., 2010). Genetic variations in the LRP2 gene inﬂuencing lipid metabo-
lism have been described (Mii et al., 2007).
LRP2 homologs have been identiﬁed in non-mammalian vertebrates,
in which mostly its roles in developmental processes were studied.
Yochem et al. characterized an LRP2 homolog, then termed LRP-1, in
the nematode Caenorhabditis elegans (C. elegans), and showed essential
roles during growth and development (Yochem and Greenwald, 1993;
Yochem et al., 1999). The work of Anzenberger at al. provided genetic
evidence of LRP2 being present in the larval zebraﬁsh. The protein
was reported to be localized in the proximal part of the pronephros
(Anzenberger et al., 2006). Christensen at al. showed that Xenopus is
expressing a LRP2 homolog in the pronephric kidney (Christensen et
al., 2008). To our knowledge, LRP2 homolog(s) have not been reported
in avian species to date.
Previous studies in the chicken kidney have shown that this organ, in
addition to liver and intestine, synthesizes apoB-100 and apoA-I as con-
stituents of plasma lipoproteins (Blue et al., 1980; Kirchgessner et al.,
1987; Tarugi et al., 1998; Walzem et al., 1999). While intestinal and
kidney apoB-100 syntheses are not known to be regulated by estrogen
(Kirchgessner et al., 1987; Lazier et al., 1994), hepatic apoB-100 synthesis
is regulated by the hormone (Capony and Williams, 1980; Chan et al.,
1976; Hermann et al., 1997; Luskey et al., 1974; Walzem et al., 1999).
In addition, the small apolipoprotein apoVLDL-II is produced in strictly
estrogen-dependent fashion exclusively in the liver (Codina-Salada et
al., 1983; Walzem et al., 1999; Wiskocil et al., 1980).
In contrast to our knowledge about apolipoprotein regulation
by estrogen, information on possible steroid sensitivity of LDL-R
family member expression in the chicken is limited to a study by
Hummel et al. on the regulation of the chicken LDL receptor by estrogen
(Hummel et al., 2003). In an effort to elucidate novel aspects of LRP2
biology, we have now molecularly characterized chicken LRP2 and re-
veal that LRP2 expression is induced by estrogen in-vivo and in-vitro.
Furthermore, we have identiﬁed potential estrogen responsive ele-
ments (ERE) in the promoter region of the gene, and demonstrate a
sex-speciﬁc difference in LRP2 levels in the kidney of mature animals.2. Material and methods
2.1. Animals
Sexually mature, Derco brown (TETRA-SL) laying hens and roosters,
as well as 10-week and 10-day old animals, respectively, of both sexes
were purchased from Diglas Co. (Feuersbrunn, Austria) andmaintained
on layer's mash with free access to water and feed under a daily light
period of 16 h.Where indicated, roosterswere treated by intramuscular
injection with 10 mg/kg body weight of 17α-ethinylestradiol (Sigma);
stock solution, 40 mg/ml 1,2-Propanediol) either once, or every 24 h
for up to 3 times, and sacriﬁced for tissue and organ retrieval. Freshly
fertilized eggswere used and incubated at 37.5 °C and 60–70% humidity.
All animal procedures were approved by the Animal Care and Use
Committee of the Medical University of Vienna.2.2. Preparation of genomic DNA and total RNA, cDNA synthesis, PCR,
DNA cloning and sequencing
Genomic DNA was isolated from EDTA–treated whole blood using
the illustra blood genomicPrepMini Spin Kit (GE Healthcare) according
to the manufacturer's instructions for nucleated blood. Total RNA was
extracted using TRI Reagent (MRC, Inc.) following the manufacturer's
instructions. Single-stranded cDNA was synthesized using SuperScript
II reverse transcriptase (Invitrogen) and oligo(dT)18-primer. PCR
ampliﬁcation was performed with a T3000 Thermocycler (Biometra)
with a touch-down program using the High Fidelity PCR EnzymeMix
(Fermentas). The ampliﬁed products were subjected to 1% agarose
gel electrophoresis and stained with ethidium bromide. Subsequently,
the PCR product was excised from the gel, and DNA was puriﬁed with
QIAquick Gel Extraction Kit (Qiagen). The puriﬁed product was cloned
into the pCR2.1-TOPOvectorwith the TOPO TACloningKit (Invitrogen),
and subsequently transformed into E. coli Top10 cells. The plasmids
were isolated using Mini-preparation. Plasmids were sent to Agowa
GmbH, Berlin, Germany for sequence analysis.
The following LRP2-speciﬁc primers were used: Gallus gallus:
forward primer 2, 5′-GGA GTG TTA GCG ATT GGA GGC-3′ and reverse
primer 2, 5′-CCT CTT TAA CAA GAT TGG CGG-3′; forward primer 3,
5′-AAA GGC AAA GGA GGC AGG AG-3′ and reverse primer 3, 5′-CCG
TAG GAG AAC AGC GCT TG-3′; forward primer 2, 5′-GGA GTG TTA
GCG ATT GGA GGC-3′ and reverse primer 4, 5′-CCA CAC TAC CAG CTC
CTG TTA-3′. Homo sapiens: forward primer 5, 5′-GAC GCA CGG GCC
ATA GTT TGC-3′ and reverse primer 5, 5′-TTT AGG AGG CTG AGG CAG
GCG G-3′.
In order to identify potential estrogen responsive elements and for
chicken LRP2 sequence veriﬁcation, we used primers upstream of the
designated exon 1 in the genomic sequence found in the galline geno-
mic database (NCBI, gene ID 424168). A new ﬁrst exon and a large
ﬁrst intron were identiﬁed by using the following pimers: forward
primer 1, 5′-ATG GGA ACT CGG CAG CAG ACG-3′ and reverse primer
1, 5′-TGA CAG CGA TAC TGG CAG CTC-3′. The obtainedmRNA sequence
corresponding to chicken LRP2 was deposited in EMBL Nucleotide
Sequence Database under the accession HE578280.
2.3. Quantitative real‐time PCR
Quantitative real‐time PCR (qPCR) was performed with the
LightCycler 480 system (Roche) using the LightCycler FastStart DNA
Master SYBR Green I Kit (Roche). The following primers were used:
Gallus gallus: LRP2, forward primer 2 and reverse primer 4; β-actin,
forward primer, 5′-AGCTATGAACTCCCTGATGG-3′ and reverse primer,
5′-ATC TCC TTC TGCATC CTG TC-3′.Homo sapiens: LRP2, forward primer,
5′-GCT GCA GAA AGT CTG GCT GTA-3′ and reverse primer, 5′-TAC TCT
CCC AAT GTA TGC GCG G-3′; β-actin, forward primer, 5′-GCG GGA AAT
CGT GCG TGA CAT T-3′ and reverse primer, 5′-GAT GGA GTT GAA GGT
AGT TTC GTG-3′; apolipoprotein AI (Apo AI), forward primer, 5′-GGC
AGC AAG ATG AAC CCC CCC-3′ and reverse primer, 5′-CTG CCT CAG
GCC CCT CTG TCT C-3′, and for estrogen receptor α (ERα), forward
primer, 5′-ACT ATG CTT CAG GCT ACC A-3′ and reverse primer, 5′-CAA
GGC ACT GAC CAT CTG-3′. Diluted cDNA samples were used for all
qPCR reactions. Serial dilutions of 10−1 to 10−9 of the target PCR prod-
ucts were freshly prepared. All samples were analyzed in duplicates
and compared to the serial dilutions serving as internal standard. Chicken
and human β-actin mRNA levels were measured as housekeeping genes
and used for normalization. Values are expressed in arbitrary units (AU)
relative to β-actin.
2.4. Statistical analysis
All values are expressed as means±SEM of relative mRNA levels.
The Student's t-test was employed to explore whether differences in
the parameters measured with the qPCR were statistically signiﬁcant
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ples. The signiﬁcance level was set at pb0.05 (*pb0.05, **pb0.01,
***pb0.001).
2.5. Protein expression and antibody production
A 701 bp chicken LRP2 cDNA fragment encoding the intracellular
domain (Fig. 3A) with a C-terminal 6xHis-tag was generated by
RT-PCR using the following oligonucleotides: forward, 5′-GAA TTC
GGA GTG TTA GCG ATT GGA GGC-3′ (EcoRI restriction site in bold-
face) and reverse, 5′-GCG GCC GCT TAA TGA TGA TGA TGA TGA TGA
TGC TCT TTA ACA AGA TTG GCG GTG-3′ (NotI restriction site in bold-
face, and 6xHis-tag sequence in italics). The fragment was cloned into
the pGEX-5X-1 expression vector to provide an N-terminal GST-tag.
The cloned ggGST-LRP2-His-construct was expressed in BL21 cells
(Invitrogen) and puriﬁed using Ni-NTA beads technology from QIAgen.
Antiserum against recombinant ggLRP2 was raised in adult female
New Zealand White rabbits by injections of antigen, 200 mg each, as
described previously (Hummel et al., 2003). Mouse anti-glutathione
S-transferase (GST) antibody was purchased from BD Bioscience and
used at a dilution of 1:2000.
2.6. Preparation of membrane protein extracts and cell lysates
Membraneprotein fractionswere prepared from fresh chicken tissues
as described (Stifani et al., 1988), except that the extraction buffer
contained 5% Triton X-100. The clear supernatant, designated the
membrane extract, was either used immediately or quickfrozen in
liquid nitrogen and stored at −80 °C until use. For cell lysis, mono-
layers were washed three times with phosphate-buffered saline
(PBS), scraped from the dishes with a rubber policeman, centrifuged
at 2000 ×g for 5 min, and the cell pellet was solubilized by addition of
buffer B (200 mM Tris-maleate, pH 6.5, 2 mM CaCl2, complete protease
inhibitor cocktail (Roche), and 1.4% Triton X-100). The cell extracts
were centrifuged at 300,000 ×g (Beckman TLA 100.3 rotor) for 40 min
at 4 °C and the pellets discarded. The supernatants were subjected to
one-dimensional SDS-PAGE as described below.
2.7. SDS-polyacrylamide gel electrophoresis and immunoblotting
ForWestern blotting, protein concentrationswere determined by the
method of Bradford (Bio-Rad), aliquots of extracts were subjected to 6%
or 12% SDS-PAGE under non-reducing conditions, and the separated
proteins electrophoretically transferred to nitrocellulose membranes
(Hybond-C Extra; Amersham Biosciences). The amounts loaded were
monitored by Ponceau S staining of themembranes. Nonspeciﬁc binding
sites were blocked with TBS (20 mM Tris–HCl, pH 7.4, and 137 mM
NaCl) containing 5% (w/v) nonfat drymilk and 0.1% Tween-20 (blocking
buffer) for 1 h at room temperature. GgLRP2 was detected with rabbit
anti-ggLRP2 antiserum (1:1000) followed by incubation with HRP-
conjugated goat anti-rabbit IgG (1:50,000, Sigma-Aldrich) and develop-
mentwith the enhanced chemiluminescence protocol (Pierce). For addi-
tional analyses of the loading controls (GAPDH), a monoclonal mouse
anti-panGAPDH antibody (1:20,000, Sigma-Aldrich) was used in combi-
nation with an HRP-conjugated goat anti-mouse IgG (1:20,000, Jackson
Immuno Laboratories, Inc.), and the blots were developed as described
above to detect the ~37 kDa signal.
2.8. Immuno-histo- and -cytochemistry
Freshly isolated tissueswere ﬁxed overnight in 4% paraformaldehyde
and embedded in parafﬁn using an Excelsior embedding machine.
Sections of 5 μm were cut on a Microm HM335E microtome, ﬁxed
on Polysine slides (Menzel-Glaeser) and dried overnight at 37 °C.
The slices were deparafﬁnized in xylol exchange medium XEM-200
(Vogel, Giessen, Germany) by gentle shaking for 20 min. For rehydration,the tissues were consecutively washed in 100%, 90%, 70%, 50%, and
30% ethanol. Primary kidney cells were grown on chamber slides
(Nunc, Inc.) and ﬁxed by incubation with ice-cold acetone:methanol
(1:1, vol:vol) for 10 min. Cells were rinsed 3×5 min with PBS.
Nonspeciﬁc binding of antibodies was inhibited by blocking with
PBS containing 1% BSA and 3% inactivated goat serum for 1 h at RT.
The sectionswere incubated overnight at 4 °Cwith the appropriate anti-
bodies in blocking solution. For immunoﬂuorescence, the sections were
rinsed 3×5 min in PBS and incubated with goat α-rabbit ﬂuorescence-
labeled secondary antibodies (Alexa Fluor 488 conjugated, 1:1000) for
1 h. Counterstaining of cell nuclei was performed with DAPI (1:1000).
Specimens were mounted in ﬂuorescent mounting media (DAKO) and
analyzed by ﬂuorescence microscopy (Axiovert 135, Zeiss). For biotin
staining, the sections were rinsed 3×5 min in PBS and incubated with
biotinylated goat α-rabbit secondary antibody (1:500 dilution, Sigma)
for 1 h. After rinsing 3×5 min in PBS, the slides were incubated with
Streptavidin Peroxidase Polymer (1:200, Sigma) for 1 h. For the color
reaction, the sectionswere incubatedwith AEC+Substrate-Chromogen
(ready-to-use solution, DAKO). The specimens were mounted in
Glycergel MountingMedium (DAKO) and analyzed by light microscopy
(Axiovert 10, Zeiss).
2.9. Cell culture
The cell lineHEK-293 (human embryonic kidney cells)was purchased
fromCell Lines Service (Eppelheim, Germany). These cells were originally
isolated from primary human embryo kidney cells transformed by
sheared adenovirus 5DNA(Grahamet al., 1977). HEK-293 cellswere cul-
tivated in Dulbecco's Modiﬁed Eagle Medium/Nutrient Mixture F-12
Ham. The medium contained 10% fetal calf serum (FCS), 2 mM L-gluta-
mine, 0.1 mg/ml streptomycin, and 100U/ml penicillin, and the cells
were cultured in a humidiﬁed 95% air/5% CO2 incubator. Experiments
were performed in phenol-free media with 10% serum with or without
addition of 17α-ethinylestradiol as described below.
Primary chicken kidney epithelial cells were isolated from four
kidneys pooled from 1 to 3 day old animals of undetermined sex as
described previously (Ogburn et al., 1998). Brieﬂy, kidneys were re-
moved and thoroughly rinsed in PBS. The tissue was then minced into
smaller fragments and incubated in an enzyme solution containing
1 mg/ml type II collagenase (Sigma) in PBS for 30 min at 37 °C. After
collagenase treatment, cells were ﬁltered through a 70 μm nylon mesh,
washed twice with PBS, and resuspended in culture medium. Cells were
grown in Quantum epithelial medium (PAA, Linz, Austria) supplied
with 100 U/ml penicillin in a humidiﬁed 95% air/5% CO2 incubator.
Prior to mRNA extraction or protein isolation, the cells were grown
to reach 60–70% conﬂuency. Where indicated, cells were treated by
addition to the medium of 17α-ethinylestradiol dissolved in ethanol
to a ﬁnal concentration of 50 nM or with vehicle alone.
2.10. Reporter constructs, transfections and luciferase assays
A 905 bp fragment containing the ERE and its ﬂanking Sp1 sites was
ampliﬁed using the forward primer 5′-ATACGCGTAAAGGCAAAGGAG
GCA GG A-3′ and the reverse pimer 5′-ATC TCG AGT GGG CAG ACC TGC
ATT AC-3′ (MluI and XhoI restriction sites in boldface). This sequence
was inserted upstream of the promoter-luc+transcriptional unit of
the pGL3-Promoter Vector to determine the functionality of the putative
enhancer elements. The empty pGL3-Promoter Vector, the pGL3-Control
Vector, the pRL-TK (Promega) and the pEGFP-N1 (Clontech) were used
as controls.
HEK-293 cells were grown to conﬂuency in Dulbecco's Modiﬁed
Eagle Medium/Nutrient Mixture F-12 Ham. The medium contained
10% fetal calf serum (FCS), 2 mM L-glutamine, 0.1 mg/ml streptomy-
cin, and 100 U/ml penicillin, and the cells were cultured in a humid-
iﬁed 95% air/5% CO2 incubator. Experiments were performed in
phenol red- and serum-free medium.
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(Invitrogen) according to the manufacturer's instructions. HEK-293
cells were plated on 12-well plates and transfected with 1.6 μg of
pGL3 vectors or a GFP expression vector, and co-transfected with
0.16 μg of pRL-TK vector (internal control). After 6 h the medium
was replaced and cells were treated with vehicle alone or with a ﬁnal
concentration of 50 nM estrogen in phenol red- and serum-free me-
dium. After 24 h, the cells were harvested in passive lysis buffer
(Promega) and analyzed using the Dual-Luciferase Reporter Assay
System (Promega). Luminescence was measured using a Victor3V
(PerkinElmer) reader and reported as a ratio of ﬁreﬂy luciferase/Renilla
luciferase.3. Results
3.1. Nucleotide sequence analysis reveals alternative ﬁrst exon
We identiﬁed transcripts of 13,935 bp (ENSGALT00000017651) and
13,938 bp (ENSGALT00000020276), respectively, in the Ensembl chick-
en genome database, and a 15,165 bp transcript with the accession
number XM_422014 (NCBI). For chicken LRP2 sequence veriﬁcation,
we used primers upstream of the designated exon 1 of gene ID
424168 (NCBI) as described in detail inMaterial andmethods. For anal-
ysis of the 5′ region and for identiﬁcation of potential estrogen respon-
sive elements, total RNA from chicken kidney was reverse-transcribed
into cDNA, and PCR was performed using forward and reverse primer
1 (see Material and methods). The obtained 971 bp sequence aligned
with the sequence of contig 19.532 found on galline chromosome 7, but
the predicted sequences in the region of the ﬁrst exon and intron were
different from the sequences we obtained. We identiﬁed a 95 bp ﬁrst
exon and a 18,937 bp long ﬁrst intron, resulting in the longest open read-
ing frame (ORF) by comparisonwith the predicted sequence (Fig. 1). The
two designated LRP2 gene sequences, ENSGALG00000010858 (Ensembl
chicken genome database) and 424168 (NCBI), lack parts of the 5′-region
as detailed in Fig. 1. The newly revealed transcript spans 13,977 bp,
which encodes a protein of 4658 amino acids. There is 73.0% identity be-
tween the human and avian LRP2 protein sequences. Themature protein
has a calculatedmolecularmass of 521.39 kDa. Chicken (Gallus gallus; gg)
LRP2 is a predicted type I transmembrane protein consisting of a 31
amino acid signal peptide, an extracellular region of 4391 amino acids,
and a single transmembrane domain of 23 amino acids. An intracellular
C-terminal region of 213 residues contains three (FX)NPXY signals for
coated pit-mediated internalization, similar to the motif (VD)NKNY in
the cytoplasmic tail of human LRP2. As the extracellular region of itsFig. 1. Partial genomic organization of the chicken LRP2 locus on gg chromosome 7. Top,
scheme representing contig 19.532 on chicken chromosome 7. The newly identiﬁed ﬁrst
intron (intron 1, 18,937 bp) and exon 1 (95 bp) are indicated. The resulting transcript is
predicted to yield an open reading frame encoding a 4658‐residue protein. As indicated
in the two bottom representations, the two previously reported LRP2 gene sequences,
ENSGALG00000010858 (Ensembl chicken genome database) and 424168 (NCBI), have
multiple sequence differences. As a consequence, the predicted transcript of the NCBI
gene sequence lacks parts of the ﬁrst exon, resulting in a shorter open reading frame
(NCBI XM_422014, 4605 aa), whereas ENSGALG00000010858-derived transcripts
ENSGALT00000017651 and ENSGALT00000020276 predict the start codon at the indicated
position, and yield proteins of 4644 and 4645 amino acids, respectively.mammalian counterparts, ggLRP2 contains four clusters of cysteine-rich
LA-repeats, characteristic of the LDLR superfamily of receptors (Hjalm
et al., 1996). Each of the clusters are comprised of a speciﬁc number of
LA-repeats and represent a putative ligand binding site for a diverse
group of ligands; for instance, the second cluster binds ApoE-β-VLDL,
lactoferrin, aprotinin, lipoprotein lipase, and receptor-associated protein
(RAP) (Dolmer and Gettins, 2006; Orlando et al., 1997).
3.2. Analysis of LRP2 transcript levels and protein localization
To gain insight into the biology of ggLRP2, we ﬁrst determined the
tissue expression pattern of chicken LRP2 at the transcript level. As
shown in Fig. 2, among the tissues analyzed by quantitative real-time
PCR, the highest expression was found in kidney, where the level is up
to 400 times higher than in all other tissues. Interestingly, we observed
a signiﬁcantly higher level of LRP2 transcript in the kidneys of hens than
of roosters, and in testes, the level was 30 times higher than in the
ovary, indicating that certain chicken tissues show sex-dependent
differences in LRP2. To substantiate this ﬁnding, we analyzed the ex-
pression of LRP2 at both the transcript and protein levels in 10-day
old chicks, 10-week old immature, and adult animals (>25 week
old). To this end, we ﬁrst raised a rabbit antiserum against chicken
LRP2. A ggLRP2 fragment corresponding to amino acid sequences
4437 to 4654 (Fig. 3C) was produced recombinantly, expressed as a
His6-tagged GST-fusion protein in BL21 cells, puriﬁed, and used to
immunize rabbits. The resulting antiserum, directed against the
C-terminal region of LRP2, recognized a protein of about 600 kDa in
chicken kidney, whereas the pre-immune rabbit serum did not
show any reactivity (Fig. 3D). We used this antiserum to analyze in
greater detail the expression of ggLRP2 in kidneys byWestern blotting,
in parallel to measurements of transcript levels. As shown in Fig. 3B,
therewas signiﬁcantlymore LRP2 protein in kidneys of sexuallymature
hens than in those from roosters, in good agreement with an observed
threefold higher ggLRP2 transcript level in the kidneys of females than
inmales (Fig. 3A). In kidneys of ten-day aswell as ten-week old animals,
no signiﬁcant differences between the sexes in LRP2 expression were
observed at both the transcript and the protein level.
Next, immunoﬂourescence staining of kidney sections of laying
hens and roosters with our anti-chicken LRP2 antibody revealed
that LRP2 is predominantly localized to the apical surface of proximal
tubules (Fig. 4A), clearly seen in the merged image (lefthand bottom
photograph). This localization was conﬁrmed by staining with the
anti-chicken LRP2 antiserum followed by biotinylated secondary anti-
body and detection by streptavidin-HRP-catalyzed color reaction
(Fig. 4B). No staining by either method was observed when sections
were incubated with pre-immune serum (Fig. 4). Furthermore, the
data of Fig. 4B show that immunohistochemistry also reveals higher
levels of LRP2 in female than in male kidney, and that the localization
of the receptor is identical in the kidneys of both sexes (Fig. 4B, panels
1 vs. 2).
3.3. Estrogen regulates LRP2 expression in the kidney and in cultured cells
To directly investigate the effects of estrogen, we treated mature
roosters with estrogen, a treatment shown to induce dramatic meta-
bolic changes in these animals (Chan et al., 1976; Kirchgessner et al.,
1987; Lazier et al., 1994; Luskey et al., 1974; Walzem et al., 1999). The
roosters were treated either with vehicle alone or with one to three
doses of 10 mg estrogen/kg bodyweight each, administered every
24 h. As described in the legend to Fig. 5, control and treated animals
were sacriﬁced at different time points and subsequently quantitative
real-time PCR was performed to determine renal LRP2 transcript
levels (Fig. 5A). 24 h after a single dose of estrogen, the LRP2 mRNA
level increased more than 4-fold (bar 2 vs. 1); at 48 h after the single
dose (bar 3), the level had returned to that in untreated roosters, and
remained low for another 24 h (bar 4). However, multiple estrogen
Fig. 2. Tissue distribution and levels of chicken LRP2 transcripts. Quantitative real‐time PCR was performed with the indicated tissues from laying hens andmature roosters. Chicken
β-actin mRNA levels were measured as housekeeping gene and used for normalization. Values are expressed as arbitrary units (AU) relative to those for chicken β-actin. All values
are expressed as means±SEM of relative mRNA levels from experiments performed in triplicate.
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over the given timeframe, albeit apparently blunted by consecutive
treatments (compare bars 2, 5, and 6). To evaluate the effects of estrogen
on renal levels of LRP2 protein, we performed Western blot analyses
(Figs. 5B and C). As at the transcript level, a single stimulationwith estro-
gen revealed a rapid increase of LRP2 protein after 24 h. The return to
baseline was attenuated compared with that of the transcript levels
(Fig. 5B, lanes 1–4) after the single dose; however, multiple doses led
to elevated levels of protein that were more persistent than the increase
in transcript Fig. 5C). These data indicate strong effects of estrogen on
transcription of the LRP2 gene, in turn leading to increased levels of theFig. 3. LRP2 expression in kidneys of young, immature, and adult animals. A: Quantitative
shown is representative of three individual animals. Kidneys of male and female animals age
quantitative RT-PCR experiments. All values are expressed as means±SEM of mRNA levels r
alyzed by Student's t-test (**, pb0.01). B: Triton X-100 membrane protein extracts of femal
lane) animals were subjected to SDS-PAGE under non-reducing conditions and subsequent W
levels were monitored. (MW.: LRP2 ~600 kDa, GAPDH ~37 kDa). C: protein sequence of the g
part of the predicted transmembrane domain (boxed) and the three NPXY (Asn-Pro-Xxx-T
reactivity of the antiserum (used at 1:1000 dilution) against a membrane extract of kidney
homolog migrates at approximately 600 kDa (lane 1). Lane 2, incubation with pre-immune
lane) were subjected to 6% SDS-PAGE under non-reducing conditions and processed for imreceptor protein,which at least in the kidney appears to turn over rather
slowly.
Next, we investigated the molecular basis for the sex-dependent
difference of LRP2 expression. We searched for estrogen-responsive
elements (ERE) in the gene for LRP2. By analysis in silico, we were
able to identify potential ERE in both the galline (on chromosome
7) and human (on chromosome 2) LRP2 genes (Fig. 6). The chicken
ERE, 5′-TT GGTCA GCC TGAGC CT-3′, is a palindromic sequence with
a single mismatch (in bold). Very similar elements can be found in
the promoter regions of the gene for chicken vitellogenin A2 (5′-GT
CCA AAG TCAGGTCA CAG TGAACCTGATCAAAGTT-3′), for chickenreal-time PCR was performed as described in Material and methods. Each set of data
d 10 days, 10 weeks, or at least 25 weeks were used for cDNA synthesis and subsequent
elative to those of β-actin; all experiments were performed in triplicate. Data were an-
e and male kidneys of 10 day, 10 week (30 μg protein/lane), and adult (60 μg protein/
estern blot analysis as described in Material and methods. As loading controls, GAPDH
gLRP2 fragment (residues 4437–4654) used for raising rabbit anti-LRP2 antiserum. The
yr) internalization motifs (shaded) are indicated. D: Western blot demonstrating the
, the main expression site of LRP2; as mammalian LRP2 (Saito et al., 1994), the chicken
serum (1:1000). Triton X-100 extracts prepared from laying hen kidney (20 μg protein/
munoblotting.
Fig. 4. Localization of LRP2 in chicken kidney. A: Immunoﬂuorescence staining (see Material and methods) of parafﬁn sections of female kidney with anti-chicken LRP2 antiserum
(1:100) or pre-immune serum (1:100), and nuclear stainingwith DAPI (magniﬁcation, 40×). B: Parafﬁn sections of laying hen (B1. and B3.) and rooster (B2.) kidneyswere incubatedwith
anti-chicken LRP2 antiserum (1:1000) or with preimmune serum (1:1000). After the primary antibody, biotinylated goat α-rabbit secondary antibody (1:500 dilution) was used, and
slides were incubated with Streptavidin Peroxidase Polymer (1:200). AEC+Substrate-Chromogen was used to detect LRP2 by color reaction. Magniﬁcation, 20×.
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CAG TGACC-3′, −178: 5′-GGTCA GAC TGACC-3′), and chicken oval-
bumin (−47/−43: 5′-TG GGTCA-3′, a “half ERE”) (Klinge, 2001). In
the human LRP2 gene we found the ERE sequence, 5′-T GGTCA GGC
TGGTC TCG AAC TCT TGACCTC-3′, which is identical to the element
existing in the human breast and ovarian cancer susceptibility gene
BRCA1. We conﬁrmed these ﬁndings by sequence analysis, which lo-
cated the ERE of the ggLRP2 gene 1659 bp upstream of the start
codon (Fig. 6A); the ERE of the human LRP2 gene is situated in intron
38 of the gene sequence (Fig. 6A). Furthermore, we identiﬁed four Sp1
sites ﬂanking the ERE in the galline LRP2 promoter region, an important
ﬁnding in regards to the possible mechanism underlying the estrogen
induction of this gene (see Discussion). A schematic overview of
the genomic organization is shown in Fig. 6B.
These ﬁndings prompted us to attempt to shed light on LRP2 regula-
tion by estrogen in human and galline cells. The effect of estrogen on
human LRP2 expression was studied in an established cell line derived
from human embryonic kidney (HEK-293). In this cell line, quantitative
real-time PCR demonstrated an increase in LRP2 transcription relative to
controls upon exposure to 50 nM estrogen. A signiﬁcant induction was
observed after 24 h, (Fig. 7; pb0.05). The mRNA levels of apolipoprotein
(Apo) AI did not respond to estrogen treatment under these conditions,
in agreement with published data (Harnish et al., 1998; Staels et al.,
1989). As a positive control, the transcription of ERα, which is knownpos-
itively regulated by hormone treatment, was analyzed (Hofmeister et al.,
2012; Kummer et al., 2011; Treilleux et al., 1997).We indeed observed an
approximately 5-fold transcript induction after 48 h.
Finally, we isolated primary chicken kidney epithelial cells from the
organs of 1–3 day old chicks of undetermined sex. By immunﬂuorescencestaining (Fig. 8A) of primary cells with anti-chicken LRP2 antibody, we
demonstrated that LRP2 is indeed expressed in these cells. To study the
estrogen effects on galline LRP2 in the cultured kidney cells, we
treated the cells with estrogen for 24 h. Quantitative real-time PCR
was performed in order to determine the relative mRNA levels before
and after estrogen treatment. As shown in Fig. 8B, a signiﬁcant increase
in the transcription of LRP2 mRNA was noted after 24 h. As in Figs. 3
and 5, the estrogen effects on transcription correlate well with those at
the protein level observed by Western blotting of lysates of primary
chicken kidney epithelial cells (Fig. 8C).
4. Discussion
LRP2 (also termed gp330 or megalin) is the largest known mem-
ber of the low-density lipoprotein receptor (LDLR) family and arguably
possesses the broadest ligand spectrum of these membrane proteins.
Although our knowledge about functions and regulation of mammalian
LRP2s is extensive, insights into the properties of this receptor in other
vertebrates may reveal important additional biological details. Thus,
the current studies were focused on the completion of the molecular
characterization, on the elucidation of regulatory features, and on
gaining insights into possible biological roles of the homolog of the
giant membrane protein in the chicken. Careful analysis of the ggLRP2
locus on chromosome 7 revealed that published reports about genomic
structure and transcript sequence were largely correct. However, our
inspection of and experiments to re-evaluate the sequence information
revealed additional interesting details (Fig. 1). An additional 95 bp
exon, separated by a newly deﬁned 18,937 bp intron from the hitherto
presumed ﬁrst exon, was demonstrated by reverse transcription PCR,
Fig. 5. Effects of estrogen on LRP2 expression in rooster kidney. Samples for qPCR (A) or
Western blotting (B and C) were prepared as described in Material and methods from
kidneys of roosters treated with or without estrogen (each dose consisted of vehicle
alone or 10 mg/kg bodyweight) as follows: 1, vehicle only; 2, a single dose at 0 h,
sacriﬁced at 24 h; 3, a single dose at 0 h, sacriﬁced at 48 h; 4, a single dose at 0 h,
sacriﬁced at 72 h; 5, 1 dose each at 0 and 24 h, sacriﬁced at 48 h; and 6, 1 dose each
at 0, 24, and 48 h, sacriﬁced at 72 h. A: Quantitative real-time PCR of LRP2 mRNA. All
values are expressed as means±SEM of mRNA levels relative to those of β-actin
from experiments performed in triplicate. Data were analyzed by using the Student's
t-test (** pb0.01). B and C: per lane, 20 μg protein of the indicated Triton X-100 kidney
membrane extracts were subjected toWestern blot analysis following SDS-PAGE under
non-reducing conditionswith anti-chicken LRP2 antiserum(1:1000 dilution) as described
inMaterial andmethods. The anti-panGAPDH antibody (1:20,000)was used to detect the
product of the housekeeping gene. (MW.: LRP2 ~600 kDa, GAPDH ~37 kDa).
55J.A. Plieschnig et al. / Gene 508 (2012) 49–59resulting in a transcript of 13,977 bp specifying a 4658-residue protein.
GgLRP2 shows all of the hallmark structural elements and the domain or-
ganization typical of this endocytic receptor, including three (FX)NPXY
internalization motifs in the 213-residue cytoplasmic domain and four
clusters of ligand-binding repeats in the large extracellular portion
(Saito et al., 1994). Human LRP2 shows high endocytic activity mediated
by tyrosine-based endocytic motifs within the cytoplasmatic domain,
which also harbors several putative phosphorylationmotifs correspond-
ing to protein kinase C (PKC), protein kinase A (PKA), casein kinase-II
(CK-II) and glycogen synthase kinase-3 (GSK3) phosphorylation sites
(Marzolo and Farfan, 2011). All of thesemotifs are present in the chicken
protein. Yuseff at al. have shown that LRP2 is constitutively phosphory-
lated by GSK3 at a PPPSPmotif enclosed in a proline-richmotif of the cy-
toplasmic tail (Yuseff et al., 2007), exactly as in the chicken LRP2's tail.
Besides the two proline-richmotifs, a PDZ-bindingmotif has been impli-
cated in the interaction of LRP2with ligands (Marzolo and Farfan, 2011).
Again, both the PPPSP motif and PDZ-binding motif are conserved in
LRP2 sequences from different species including man, rodents, and
chicken (Marzolo and Farfan, 2011). At the protein level, the sequence
identity of galline LRP2 with known mammalian LRP2 is 70–73%, with
an identity between LRP2 from, e.g., man and rat of 77%. The observed
high degree of conservation of the gene for the extremely large single-
chain protein LRP2 from avians to mammals further supports roles for
the receptor that are common in awide range of species despite different
physiological settings.
The analogies between LRP2 frommammals and the chicken extend
to the tissue distribution pattern, in that the kidney is the major site of
expression,with high levels also observed in testes (Fig. 2). The renal re-
ceptor is localized to the apical aspect of the epithelial cells lining the
proximal convoluted tubules (Fig. 4A), where it likely mediates the
resorption of certain proteins from the glomerular ultraﬁltrate, as
has been demonstrated in normal as well as genetically modiﬁed
mice (Leheste et al., 2003; Vegt et al., 2011). Quite unexpectedly and todate not observed in any other species, qPCR experiments suggested
that LRP2 is expressed at signiﬁcantly higher levels in the kidneys of ma-
ture hens than of roosters (Fig. 3C). This important observation was sub-
stantiated by immunological studies with a newly generated rabbit-anti
ggLRP2 antiserum (Fig. 3D), which was also used to demonstrate that
the receptor's apical localization in the proximal tubular epithelium was
unchanged at the higher levels found in female kidneys (Fig. 4B).
Since the observation of an apparent sex difference in LRP2 levels is a
novel aspect thatmay ormay not be typical of or limited to the chicken,
several experiments to characterize the details of this property were
performed. Estrogen is known to have dramatic effects on the expres-
sion of genes in the chicken, particularly of those involved in metabolic
pathways related and/or essential to the reproductive effort of the hen,
i.e., oocyte development and egg-laying (Schneider, 2007). The body of
investigations on estrogen's effects in the chicken has been performed
by treatingmature roosterswith pharmacological doses of the hormone
(i.e., 17a-ethinylestradiol or 17b-estradiol), whereby a “female” pro-
gram is rapidly switched on. This effect is closely related to the pivotal
function of the liver in synthesizing yolk precursor molecules such as
very low‐density lipoprotein (VLDL) particles for uptake into growing
oocytes (Schneider, 2009). There appears to be little difference in
the efﬁcacy of gene induction by acute hormonal stimulus of roosters
versus that leading to elevated levels by the chronic estrogen status of
laying hens. While both acutely and chronically elevated estrogens
raise yolk precursor protein levels, studies on apolipoprotein (apo)-
VLDL-II, apoB, and vitellogenin, 3 major molecules destined for oocyte
uptake, have uncovered subtle differences in the induction of these
genes (Bergink and Wallace, 1974; Jost et al., 1986; Kirchgessner et al.,
1987; Noteborn et al., 1986; Wang and Williams, 1983; Wiskocil et al.,
1980). For instance, Bergink and Wallace (1974) observed that upon an
initial estrogen administration to roosters the hepatic vitellogenin gene
is induced after a considerable lag time and more slowly than following
a second injection, which causes an immediate rise and higher ﬁnal
levels of transcript and protein. Similarly, Kirchgessner et al. (1987)
found that the induction in-vivo of apoB mRNA by estrogen shows no
lag, in contrast to that of apo-VLDL-II. The consequence of priming on
the estrogen induction of chicken hepatic genes has been proposed to
be based on a “memory” effect, which may or may not be displayed by
the gene for apo-VLDL-II (Noteborn et al., 1986; Wiskocil et al., 1980).
While extensive studies have clearly shown that the prime target
tissue for estrogens in the mature hen is primarily the liver, certain
genes are, at least to some extent, estrogen-responsive in the kidney.
For instance, apo-VLDL-II and apoB are major constituents of VLDL par-
ticles, and their hepatic expression in embryos is enhanced by estrogen,
whereas in the embryonic kidney this is the case only for apo-VLDL-II
(Lazier et al., 1994). In the adult hen, the two genes remain estrogen-
responsive in the liver, but despite demonstrated synthesis of VLDL par-
ticles in the kidney (Walzemet al., 1999), the estrogen-responsiveness of
renal apo-VLDL-II is signiﬁcantly lower, whereas apoB is unresponsive in
both intestine and kidney (Kirchgessner et al., 1987). Here we observed
that the induction of LRP2 in the kidney at both the transcript and pro-
tein level is massive and rapid, as it occurs within 24 h, and the return
to baseline appears to be attenuated by repeated hormone administra-
tion (see Fig. 5 for details), possibly via the above mentioned „memory“
effect. Furthermore, the observation of elevated LRP2 levels in kidneys in
females is corroborated by the fact that LRP2 expression in the kidneys of
mature roosters is induced by administration of estrogen (Fig. 5), com-
patiblewith a direct effect of the hormone. Alternatively, the estrogen ef-
fect in-vivo might be an indirect consequence of physiological changes
due to the dramatic metabolic effects of estrogen administration (Chan
et al., 1976; Kirchgessner et al., 1987; Lazier et al., 1994; Luskey et al.,
1974; Walzem et al., 1999). This possibility seems unlikely, however, as
induction by estrogen of LRP2, at both the transcript and protein levels,
was also observed in cultured primary chicken renal epithelial cells
(Fig. 8) and incidentally also in two established human kidney cell lines
(Fig. 7). Therefore, the data suggest that we have identiﬁed the galline
Fig. 6. A: Location of estrogen-responsive elements (ERE) in the LRP2 genes of Gallus gallus and Homo sapiens. The magniﬁed regions show alignments of the respective published
Ensembl gene sequence (ENS) with the sequences we obtained for G. gallus (1; upper box) and H. sapiens (2; shaded lower box). The presumptive EREs are underlined and bold. In
chicken, the ERE sequence is located in the promoter region of LRP2, 1659 bases upstream of the start codon we identiﬁed. The ERE in the human LRP2 gene is located in intron 38.
B: Schematic representation of the localization of the four Sp1 sites relative to the ERE and the start codon in the promoter region of galline LRP2.
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the induction kinetics in this organ are similar, if not identical, to those
of hepatic estrogen-regulated genes. One consequence of the elevated
estrogen levels of the laying hen is the newly revealed sexual dimor-
phism of renal LRP2.Fig. 7. Estrogen treatment of HEK-293 cells is affecting gene expression. Quantitative real-tim
is representative of three independent experiments. The cells were treated with vehicle alo
indicated times. The mRNA levels of LRP2, Apo AI, and ERα were analyzed. All values are e
were performed in triplicate. Data were analyzed by Student's t-test (*, pb0.05).The molecular basis and biological signiﬁcance for estrogen action
on any gene in the avian kidney are unknown, and thus the identiﬁca-
tion of candidate sequences for estrogen-responsive elements (ERE)
not only in the promoter of the galline, but also of the human LRP2
gene (Fig. 6) provides initial insight into possible mechanisms for thee PCR was performed as described in Experimental Procedures. Each set of data shown
ne (open bars) or with 50 nM estrogen (gray bars) and harvested for analysis after the
xpressed as means±SEM of mRNA levels relative to those of β-actin; the experiments
Fig. 8. Localization of LRP2 in primary chicken kidney epithelial cells and induction by estrogen. The cells were isolated and prepared for immunocytochemistry with anti-chicken
LRP2 antiserum or preimmune serum (Pre-S) as described in Material and methods. A: Immunoﬂuorescence (magniﬁcation, 40×). B: Quantitative real-time PCR of LRP2 mRNA in
primary chicken kidney epithelial cells. Cells were treated with 50 nM estrogen and harvested after 24 h. All values are expressed as means±SEM of mRNA levels relative to those
of β-actin; experiments were performed in triplicate. Data were analyzed by Student's t-test (*, pb0.05). C: Determination of LRP2 protein levels in lysates of primary chicken kid-
ney epithelial cells treated (lanes 2 and 3) or not treated for 24 h (lanes 1 and 2) with 50 nM estrogen. 50 μg of protein/lane was separated by 6% (or 12%, respectively) SDS-PAGE
under non-reducing conditions and processed for Western blot analysis with rabbit anti-ggLRP2 antiserum (1:1000). The anti-panGAPDH antibody (1:20,000) was used to detect
the product of the housekeeping gene.
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sumptive ERE, it is known that they can deviate substantially from the
consensus sequence (O'Lone et al., 2004). To our knowledge, detailed
studies on the regulation by estrogen of genes specifying LDLR family
members have been performed only for the human LDLR itself
(Bruning et al., 2003; Li et al., 2001). The published data suggest that es-
trogen activation of transcription of the LDLR gene is likely effected by
ligand-dependent interaction of estrogen receptor α and the transcrip-
tion factor, Sp1 (stimulating protein-1). In fact, an estimated one-third
of known human estrogen-targeted genes associate only indirectly
with ER, via intermediary transcription factors, and Sp1 is the predomi-
nant such mediator (reviewed in e.g., O'Lone et al. 2004). This induction
pathway, referred to as transcription factor crosstalk, is one of four
proposed processes underlying estrogen signaling (for review, see
e.g. (Zhao et al., 2010)).
The identiﬁed key elements in the LDLR promoter for estrogen
action are a sterol-responsive element (SRE), 5′-ATCACCCCAC-3′, and
two Sp1 sites, 5′-CTCCTCC-3′ and 5′-CTCCTCCCC-3′ positioned upstream
and downstream, respectively, of the SRE (Bruning et al., 2003; Li et al.,
2001). Reminiscent of this arrangement of key elements in the LDLR's
promoter, in addition to the presumptive (almost perfectly palindromic)
ERE in the promoter of the ggLRP2 gene, 5′-TT GGTCA GCC TGAGC CT-3′,
sthere are also 4 elements that display the Sp1-binding site signatures,
5′-TCCC/TT-3′ or 5′-TCCCCTCC-3′, of which 2 are upstream and 2
downtream of the ERE (Fig. 6B). These elements are binding sites for
Sp1 and Sp3 proteins, which are capable of activating transcription (Li
and Davie, 2010). A ggLRP2 promoter fragment containing all four
Sp1-binding sites and the ERE was shown to induce transcription even
without estrogen treatment, as determined by a luciferase activity assay(data not shown). It is known that the transcriptional induction of
estrogen-responsive genes by estrogen can be achieved by orchestrating
complex formation betweenestrogen receptor and Sp1 (Kimet al., 2003).
Thus, in addition to direct estrogen induction via the classical ligand-
induced ERE pathway, the indirect transcription factor crosstalk pathway
engaging the Sp1 sites may well operate in mediating estrogen's action
on the ggLRP2 gene. The addition of estrogen further increased the effect
on transcriptional activation of the reporter gene (data not shown),
indicating the functionality of the ggERE and its contribution to the
complex gene regulation of the galline LRP2 gene. Future studies are
aimed at delineating the type(s) of processes that mediate the estrogen-
responsiveness of bothhuman andgalline LRP2 genes by detailed analysis
of the promoter region.
Is there a speciﬁc function of chicken LRP2 that may require, or
provide an advantage by, estrogen-regulation and/or higher renal ex-
pression in females? One possibility is that the higher levels of a re-
ceptor essential to retention of small proteins from the glomerular
ultraﬁltrate in mature females is required for coping with the grossly
altered physiological state of hens induced by estrogen (Chan et al.,
1976; Kirchgessner et al., 1987; Lazier et al., 1994; Luskey et al., 1974;
O'Lone et al., 2004; Walzem et al., 1999). The most obvious changes
occur in the levels of serum components, especially lipoproteins:
VLDL levels rise 20-50-fold during sexual maturation (i.e., at onset
of egg-laying), while the HDL fraction, predominant in roosters and
immature females, becomes negligible. Retention of important proteins,
such as apoA-I, the major apo of HDL, as well as that of low-molecular
weight proteins including vitamin- and steroid-binding proteins by
LRP2 (reviewed, e.g., in (Christensen et al., 1999; Willnow and Nykjaer,
2010)), may be particularly critical in the challenging physiological
58 J.A. Plieschnig et al. / Gene 508 (2012) 49–59condition of the laying hen. In addition or alternatively, enhanced lipo-
protein uptake into the kidney by LRP2 may be required to provide
precursors for the enhanced synthesis of apo-VLDL-II-poor VLDL
particles that supply extraoocytic target sites with energy (Walzem
et al., 1999). In conclusion, control of hepatic biosynthetic genes and
the renal LRP2 gene are tightly linked not only under chronically elevated
estrogen levels, as in laying hens, but acute estrogen administration
triggers the equivalent physiological changes and enhances renal ex-
pression of LRP2 in roosters.
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